| Catalog | name | Description | price |
|---|---|---|---|
| R-M-1433 | C-telopeptide Peptide,Cas:162929-64-8 | The C-telopeptide is an octapeptide corresponding to the C-terminus region (aa 1207-1214) of the alpha-1 chain of type 1 collagen. The presence of the C-telopeptide in urine samples is a good marker of osteoclast-mediated bone resorption observed in osteoporosis, Paget disease, primary hyperparathyroidism, renal insufficiency and bone metastases. | price> |
| R-M-1594 | Cyclo (-GRGDSP),CAS:135432-37-0 | This cyclic peptide is a potent vasodilator. It is more powerful than the linear GRGDSP in changing the vascular tone of arterioles isolated from rat cremaster muscle. | price> |
| R-M-1640 | Cyclo(RADfK),CAS:756500-23-9 | Cyclo(RADfK) is a selective α(v)β(3) integrin ligand. It has been used for research, therapy, and diagnosis of neoangiogenesis. It is also used as a negative control for the cyclo (-RGDfK-), the RGD peptide, which are modulators of cell adhesion and are recognized by several members of the integrin family. It has low affinity binding to integrin peptides. | price> |
| R-M-1687 | RGD-4C,CAS :332179-76-7 | This peptide, a double cyclic peptide, binds preferentially to integrins at sites of tumor angiogenesis and inflammed synovium in-vivo, and can be internalized into targeted cells. | price> |
| R-M-1691 | Adrenomedullin (11-50), rat,CAS:163648-32-6 | C-terminal fragment found to induce dose-dependent and endothelium-independent vasodilatation on arterial mesenteric vasculator, though inactive on the venous side of tested rat perfused mesentric bed. This peptide thus shares similar properties to those of CGRP (human). | price> |
| R-M-1760 | Polymyxin B nonapeptide TFA,Cas:2220175-42-6 | Polymyxin B nonapeptide TFA is a cyclic peptide obtained from Polymyxin B by proteolytic removal of its terminal amino acyl residue. Polymyxin B nonapeptide TFA is less toxic, lacks bactericidal activity, and retains its ability to render gram-negative bacteria susceptible to several antibiotics by permeabilizing their outer membranes. | price> |
| R-M-1770 | Polymyxin B nonapeptide,cas:86408-36-8 | Polymyxin B nonapeptide is a cyclic peptide obtained from Polymyxin B by proteolytic removal of its terminal amino acyl residue. Polymyxin B nonapeptide is less toxic, lacks bactericidal activity, and retains its ability to render gram-negative bacteria susceptible to several antibiotics by permeabilizing their outer membranes. | price> |
| R-M-1804 | Secretin (28-54), human TFA | Secretin (28-54), human TFA is a 27-amino acid residue C-terminally amidated peptide, which acts on human secretin receptors. | price> |
| R-M-1808 | LyP-1 TFA | LyP-1 TFA is a cyclic 9‐amino‐acids tumor homing peptide and selectively bind to p32 receptors overexpressed in various tumor-associated cells. | price> |
| R-M-1821 | LXW7 TFA | LXW7 TFA, a cyclic peptide containing Arg-Gly-Asp (RGD), is an integrin αvβ3 inhibitor. LXW7 has a high binding affinity to αvβ3 integrin with an IC50 of 0.68 μM. LXW7 TFA increases phosphorylation of VEGFR-2 and activation of ERK1/2. Anti-inflammatory effect. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


